Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.
Calvo-Villas
Jose-Manuel
JM
Fernández
Jose Antonio
JA
de la Fuente
Ignacio
I
Godoy
Ana Cristina
AC
Mateos
M Carmen
MC
Poderós
Concepcion
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008081:Liposomes; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D055756:Meningeal Carcinomatosis / Q000188:drug therapy*; D008875:Middle Aged; D012189:Retrospective Studies
D000964:Antimetabolites, Antineoplastic; D003692:Delayed-Action Preparations; D008081:Liposomes; D003561:Cytarabine